Followers | 68 |
Posts | 2027 |
Boards Moderated | 0 |
Alias Born | 09/27/2011 |
Saturday, March 09, 2019 1:50:22 AM
The following information provides adequate cause to question the wisdom of the FDA wanting to declare CBD's illegal for human consumption .....
A few remarks from the information imparted below seem deserving of increased scrutiny .....
"Given CBD's low affinity for the cannabinoid receptors CB1, it lacks euphoric side effects. In other words, CBD does not produce a high.
It is being evaluated as a potential treatment option for conditions such as schizophrenia."
Also .....
"CBD, if taken with a high-THC medication used to treat nausea and improve appetite, could reduce the side effects of THC, which can include paranoia. This is because CBD is an antagonist to CB1 receptors and suppresses the qualities of THC that activate these receptors."
100's of peer reviewed studies relative to CBD's have been published ..... Also ..... the hemp strain named "Charlotte's Web" ..... which has a highly elevated CBD profile ..... has been shown to be effective treating CHILDREN with chronic epileptic conditions ..... with no dangerous side-effects reported .....
https://m.benzinga.com/article/13312269
Best Wishes
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM